ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCY..TRBGCZEEHUPLSK..HRIS..MTNO........................*JJDIM360 Ver 1.28 (29 Oct 2014) - 2999001/02265590CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120160727W173deBibliographieenBibliographyfrBibliographieEP09733489.0200904152010101220131021enenen4519820080415US2016072720163020101229201052201604132016152015102820160727201630C07D 235/06 20060101AFI20120319BHEP C07D 235/08 20060101ALI20120319BHEP C07D 235/10 20060101ALI20120319BHEP C07D 235/12 20060101ALI20120319BHEP C07D 235/14 20060101ALI20120319BHEP deSELEKTIVE HISTONDEACETYLASE-HEMMERenSELECTIVE INHIBITORS OF HISTONE DEACETYLASEfrINHIBITEURS SÉLECTIFS DE L'HISTONE DÉSACÉTYLASEWO-A1-2005/028447WO-A2-2007/109178US-A1- 2005 137 234US-A1- 2007 281 934MAI ET AL: "3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydr oxy-2-propenamides as a New Class of Synthetic Histone Deacetylase Inhibitors. 2. Effect of Pyrrole-C2 and/or -C4 Substitutions on Biological Activity", JOURNAL OF MEDICINAL CHEMISTRY, vol. 47, no. 1, 21 January 2004 (2004-01-21), pages 1098-1109, XP002292253, ISSN: 0022-2623, DOI: 10.1021/jm030990+DAI YUJIA ET AL.: 'Inorganic amide hydroxamic acids as potent inhibitors of histone deacetylases' BIOORGANIC & MEDICINAL CHEMISTRY LETTERS vol. 13, 2003, pages 1897 - 1901, XP002331281LEE S. ET AL.: 'Design, synthesis, and evaluation of isoindolinone-hydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors' BIOORG MED CHEM LETT. vol. 17, no. 17, 01 September 2007, pages 4895 - 4900, XP02218493120120323VERNER, Erik1521 Notre Dame AvenueBelmont CA 94002USBALASUBRAMANIAN, Sriram1623 Howard AvenueSan Carlos CA 94070USBUGGY, Joseph, J.858 Cuesta DriveMountain View CA 94040USPharmacyclics LLC101539532P101271EP51995 East Arques AvenueSunnyvale, CA 94085USCole, William Gwynet al101372899Avidity IP Broers Building Hauser Forum 21 J J Thomson AveCambridge CB3 0FAGBATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTROSESISKTRUS200904070920090415enWO200912933520091022200943